InspireMD financials
$0.6937+0.62%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0M | $7.0M | $6.2M | $5.2M | $4.5M | $2.5M | $3.7M | $3.6M | $2.8M | $1.9M |
| Gross profit | $2.6M | $1.5M | $1.8M | $1.1M | $754.0K | $83.0K | $756.0K | $995.0K | $585.0K | $102.0K |
| Gross margin | 29.5% | 21.5% | 29.1% | 21.6% | 16.8% | 3.3% | 20.3% | 27.6% | 21.2% | 5.4% |
| Operating income | -$49.6M | -$33.5M | -$21.1M | -$18.7M | -$14.7M | -$10.4M | -$9.8M | -$7.6M | -$8.2M | -$7.6M |
| Net income | -$48.8M | -$32.0M | -$19.9M | -$18.5M | -$14.9M | -$10.5M | -$10.0M | -$7.7M | -$13.0M | -$8.5M |
| Net margin | −543.3% | −456.6% | −321.0% | −357.6% | −331.9% | −424.3% | −269.8% | −213.7% | −471.9% | −446.7% |
| Diluted EPS | $-0.76 | $-0.76 | $-0.82 | $-2.35 | $-2.03 | $-6.97 | $-4.80 | $-16.67 | $-1749.00 | $-10386.00 |
| EBITDA | -$49.1M | -$33.2M | -$20.9M | -$18.5M | -$14.6M | -$10.2M | -$9.7M | -$7.5M | -$8.1M | -$7.5M |
| Operating cash flow | -$35.1M | -$21.9M | -$16.4M | -$15.5M | -$13.2M | -$9.1M | -$9.8M | -$7.6M | -$8.1M | -$7.5M |
| Free cash flow | -$36.8M | -$23.3M | -$16.8M | -$16.0M | -$13.6M | -$9.2M | -$10.1M | -$7.7M | -$8.4M | -$7.5M |
| Diluted shares | 64.3M | 41.9M | 24.3M | 7.9M | 7.3M | 1.5M | 2.1M | 0.5M | 0.0M | 0.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.9M | $18.9M | $9.6M | $4.6M | $12.0M | $12.6M |
| Short-term investments | $45.3M | $15.7M | $29.4M | $0.00 | $22.0M | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $69.4M | $46.8M | $47.6M | $24.7M | $39.7M | $17.8M |
| Total liabilities | $14.2M | $10.7M | $8.1M | $7.3M | $6.2M | $5.6M |
| Shareholders' equity | $55.2M | $36.1M | $39.5M | $17.4M | $33.5M | $12.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology